Table 1 Patients’ Demographic and Clinical Characteristics, Tumor Features, and Outcome
Gender (M:F) | 15:5 |
|---|---|
Age (years) | 73 [62–77] |
HBV positivity (%) | 1 (5%) |
HCV positivity (%) | 6 (30%) |
NASH (%) | 3 (15%) |
Alcohol abuse (%) | 7 (35%) |
MELD score | 7 [6–10] |
AFP, (ng/mL) | 7.5 [3.2–23.5] |
CEA, (ng/mL) | 1.7 [1.1–3.3] |
CA 19.9 (UI/mL) | 16.9 [9.9–19.3] |
Tumor number (%) | |
- 1 | 14 (70%) |
- 2 | 4 (20%) |
- 3 | 2 (10%) |
Satellites lesions (%) | 3 (15%) |
Tumor max diameter (cm) | 4.3 [3–10.8] |
Edmonson-Steiner grading (%) | |
- G1 | 4 (20%) |
- G2 | 12 (60%) |
- G3 | 4 (20%) |
Microvascular invasion (%) | 7 (35%) |
Tumor staging (%) | |
- T1 | 7 (35%) |
- T2 | 7 (35%) |
- T3 | 3 (15%) |
- T4 | 3 (15%) |
Tumor recurrence (%) | 10 (50%) |
Recurrence time, (months) | 25.4 [7.4–33.5] |